您的位置: 首页 > 农业专利 > 详情页

Utilisation d'agents actifs contenant des hydroxystilbènes pour le traitement de la dépression et de l'anxiété
专利权人:
Heger;Heger, Peter; Peter;Dr. Loges + Co. GmbH
发明人:
Heger, Peter,Dr. Rettenberger, Reinhard,Spaich, Carl-Friedrich
申请号:
EP12177163.8
公开号:
EP2520183B1
申请日:
2006.02.03
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
Hydroxystilbene-containing active substance combination (I) containing at least two compounds, resveratrol and piceatannol precursors, their derivatives, stereoisomers, salts or phenolic forms, is used for preparing an agent (II) for the prevention and/or treatment of diseases caused by increased serum interleukin-6 (IL-6) level. Hydroxystilbene-containing active substance combination (I) containing at least two compounds, resveratrol and piceatannol precursors or their derivatives, stereoisomers, salts or phenolic forms, is used for preparing an agent (II) for the prevention and/or treatment of diseases caused by increased serum interleukin-6 (IL-6) level, where their occurrence and/or progress is treated by a dose of estrogen receptor-beta agonist. Independent claims are also included for: (1) a dosage form comprising active substance or (I) in a pharmaceutically or dietically acceptable carrier; and (2) an agent comprising the dosage form. ACTIVITY : Antidepressant; Antimigraine; Antiinflammatory; Cytostatic. MECHANISM OF ACTION : Estrogen receptor beta agonist; Interleukin-6 antagonist.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充